|
|
- 2017
嗜酸粒细胞与颅内动脉瘤的相关性
|
Abstract:
摘要：目的 探讨嗜酸粒细胞与颅内动脉瘤(IA)的相关性。方法 回顾性分析我院2014年1月至2015年12月住院的79例IA患者和65例对照组的外周血嗜酸粒细胞水平及相关临床资料，应用Logistics回归分析IA形成的相关危险因素。 结果 与对照组相比，IA患者嗜酸粒细胞、血小板计数明显升高[(0.18±0.12)109/L vs. (0.12±0.09)109/L；(196.44±57.33)109/L vs. (178.80±47.23)109/L，P均<0.05]，血小板分布宽度、平均血小板体积则降低[(13.95±3.332)fL vs. (15.30±3.5)fL；(11.02±1.73)fL vs. (11.66±1.31)fL，P均<0.05]；多因素Logistics回归分析显示嗜酸粒细胞是IA的独立危险因素。结论 嗜酸粒细胞升高是IA形成的独立危险因素。
ABSTRACT: Objective To assess the relationship between eosinophil count and intracranial aneurysm (IA). Methods For the retrospective study, we collected data of the count of eosinophils obtained from the peripheral blood samples and other clinical data of 79 patients with IA admitted to our hospital between January 2014 and December 2015 and 65 healthy people as control group. Risk factors for IA were analyzed by multivariate Logistics regression analysis. Results Clinical characteristics were comparable between the two groups (P>0.05). Compared with those in the control group, eosinophil and platelet counts in IA group were significantly higher [(0.18±0.12)109/L vs. (0.12±0.09)109/L; (196.44±57.33)109/L vs. (178.80±47.23)109/L, respectively; all P<0.05], while platelet distribution width (PDW) and mean platelet volume (MPV) were lower [(13.95±3.332)fL vs. (15.30±3.5)fL; (11.02±1.73)fL vs. (11.66±1.31)fL, respectively; all P<0.05]. Logistic regression analysis indicated that eosinophil was the independent risk factor for IA. Conclusion Our study demonstrated that increased eosinophil count is the independent risk factor for IA
| [1] | KUZEYTEMIZ M, DEMIR M, ？瘙？CENT？aRK M. The relationship between eosinophil and nondipper hypertension[J]. Cor Et Vasa, 2013, 55(6):e487-e491. |
| [2] | YAVUZ H, CHEE R. A review on the vascular features of the hyperimmunoglobulin E syndrome[J]. Clin Exp Immunol, 2009, 159(3):238-244. |
| [3] | KOUNIS NG, SOUFRAS GD, TSIGKAS G, et al. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease[J]. Clin Appl Thromb Hemost, 2015, 21(2):139-143. |
| [4] | CHALOUHI N, HOH BL, HASAN D. Review of cerebral aneurysm formation, growth, and rupture[J]. Stroke, 2013, 44(12):3613-3622. |
| [5] | FR？ZSEN J, PIIPPO A, PAETAU A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture histological analysis of 24 un-ruptured and 42 ruptured cases[J]. Stroke, 2004, 35(10):2287-2293. |
| [6] | KHOURY P, GRAYSON PC, KLION AD. Eosinophils in vasculitis: Characteristics and roles in pathogenesis[J]. Nat Rev Rheumatol, 2014, 10(8):474-483. |
| [7] | SWEETNAM PM, THOMAS HF, YARNELL JWG, et al. Total and differential leukocyte counts as predictors of ischemic heart disease: The Caerphilly and Speedwell studies[J]. Am J Epidemiol, 1997, 145(5):416-421. |
| [8] | DEMIR M, CO？瘙？CAR S, MELEK M. Evaluation of plasma eosinophil count and mean platelet volume in patients with coronary slow flow[J]. Clinics, 2014, 69(5):323-326. |
| [9] | KE？sEOGLU S, DEMIR M, UYAN U, et al. The effects of ？？eosinophil？？ on the left atrial thrombus in patients with atrial fibrillation[J]. Clin Appl Thromb Hemost, 2014, 20(3):285-289. |
| [10] | DEMIR M, KECEOGLU S, MELEK M. The relationship between plasma eosinophil count and coronary artery ectasia[J]. Cardiol Res, 2013, 4(4-5):159-164. |
| [11] | TANAKA M, FUKUI M, TOMIYASU K, et al. Eosinophil count is positively correlated with coronary artery calcification[J]. Hypertens Res, 2012, 35(3):325-328. |
| [12] | FREEMAN AF, COLLURA-BURKE CJ, PATRONAS NJ, et al. Brain abnormalities in patients with hyperimmunoglobulin E syndrome[J]. Pediatrics, 2007, 119(5):1121-1125. |
| [13] | WALKER AE, SEIBERT SM, DONATO AJ, et al. Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults[J]. Hypertension, 2010, 55(2):363-369. |
| [14] | MOOSBAUER C, MORGENSTEM E, CUVELIER SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure[J]. Blood, 2007, 109(3):995-1002. |
| [15] | ROHRBACH MS, WHEATLEY CL, SLIFMAN NR, et al. Activation of platelets by eosinophil granule proteins[J]. J Exp Med, 1990, 172(4):1271-1274. |
| [16] | WANG JG, MAHMUD SA, THOMPSON JA, et al. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: A potential mechanism for thrombosis in eosinophilic inflammatory states[J]. Blood, 2006, 107(2):558-565. |
